Vamorolone
New Drug Approvals
JULY 25, 2025
October 2014). “Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy” The Journal of Cell Biology. . “VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects” EMBO Molecular Medicine. 5 (10): 1569–1585. PMC 3799580.
Let's personalize your content